Orion OYJ (OTCMKTS:ORINY) Shares Gap Down – What’s Next?

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) gapped down prior to trading on Wednesday . The stock had previously closed at $41.04, but opened at $37.9875. Orion OYJ shares last traded at $37.9875, with a volume of 105 shares traded.

Analysts Set New Price Targets

Separately, Danske lowered Orion OYJ from a “buy” rating to a “hold” rating in a research report on Thursday, January 15th. One research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold”.

Orion OYJ Stock Down 7.4%

The company has a market cap of $10.72 billion, a P/E ratio of 18.62 and a beta of 0.06. The company has a quick ratio of 1.58, a current ratio of 2.40 and a debt-to-equity ratio of 0.09. The company has a fifty day moving average of $39.84 and a 200 day moving average of $37.71.

Orion OYJ (OTCMKTS:ORINY) last posted its earnings results on Thursday, February 12th. The company reported $1.08 earnings per share for the quarter. The company had revenue of $809.41 million for the quarter. Orion OYJ had a return on equity of 47.67% and a net margin of 26.68%. On average, research analysts anticipate that Orion OYJ Unsponsored ADR will post 1.18 earnings per share for the current fiscal year.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.